Genetic risk score based on the prevalence of vertebral fracture in Japanese women with osteoporosis
Heying Zhou,
Seijiro Mori,
Tatsuro Ishizaki,
Atsushi Takahashi,
Koichi Matsuda,
Yukihiro Koretsune,
Shiro Minami,
Masahiko Higashiyama,
Shinji Imai,
Kozo Yoshimori,
Minoru Doita,
Akira Yamada,
Satoshi Nagayama,
Kazuo Kaneko,
Satoshi Asai,
Masaki Shiono,
Michiaki Kubo,
Hideki Ito
Affiliations
Heying Zhou
Center for the Promotion of Clinical Investigation, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
Seijiro Mori
Center for the Promotion of Clinical Investigation, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan; Corresponding author at: Center for the Promotion of Clinical Investigation, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae, Itabashi, Tokyo 173-0015, Japan.
Tatsuro Ishizaki
Research Team for Human Care, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
Atsushi Takahashi
Laboratory for Statistical Analysis, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan; Laboratory for Omics Informatics, Omics Research Center, National Cerebral and Cardiovascular Center, Osaka, Japan
Koichi Matsuda
Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Yukihiro Koretsune
National Hospital Organization, Osaka National Hospital, Osaka, Japan
Shiro Minami
Department of Bioregulation, Institute for Advanced Medical Research, Nippon Medical School, Kawasaki, Japan
Masahiko Higashiyama
Osaka Medical Center for Cancer & Cardiovascular Diseases, Osaka, Japan
Shinji Imai
Department of Orthopaedic Surgery, Shiga University of Medical Science, Shiga, Japan
Kozo Yoshimori
Japan Anti-Tuberculosis Association, Fukujuji Hospital, Tokyo, Japan
Minoru Doita
Department of Orthopedic Surgery, School of Medicine, Iwate Medical University, Morioka, Japan
Akira Yamada
Clinical Trial Promotion Headquarters, Aso Iizuka Hospital, Tokyo, Japan
Satoshi Nagayama
Department of Gastroenterological Surgery, Cancer Institute Hospital, Tokyo, Japan
Kazuo Kaneko
Department of Orthopaedic Surgery, Juntendo University School of Medicine, Tokyo, Japan
Satoshi Asai
Division of Pharmacology, Nihon University School of Medicine, Tokyo, Japan
Masaki Shiono
Tokushukai Medical Corporation, Kanagawa, Japan
Michiaki Kubo
Laboratory for Genotyping Development, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan
Hideki Ito
Local Independent Administrative Agency, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan
A genetic risk score (GRS) was developed for predicting fracture risk based on the prevalence of vertebral fractures in 441 Japanese females with osteoporosis. A total of 979 (858 nonsynonymous and 121 silent) single-nucleotide polymorphisms (SNPs) located in 74 osteoporosis-susceptibility genes were genotyped and evaluated for their association with fracture prevalence. Four SNPs (protein kinase domain containing, cytoplasmic [PKDCC; rs4952590], CDK5-regulatory subunit-associated protein 1-like 1 [CDKAL1; rs4712556], wingless-type MMTV-integration site family member 16 [WNT16; rs2707466], and G-patch domain-containing gene 1 [GPATCH1; rs10416265]) showed a significant association (p < 0.05) with the fracture, in which the minor allele of the former two SNPs was the protective allele and that of the latter two SNPs was the risk allele. Applying a dominant-genetic model, we allotted −1 point each to the protective-allele carriers and 1 point each to the risk-allele carriers, and GRS values were calculated as the sum of the points. The receiver-operating characteristic curves showed that GRS adequately predicted vertebral fracture. For the model predicted by the GRS with and without the effect of age, areas under the curves were 0.788 (95% confidence interval [CI]: 0.736–0.840) and 0.667 (95% CI: 0.599–0.735), respectively. Multiple logistic regression analysis revealed that the odds ratio for the association between fracture prevalence and GRS was 3.27 (95% CI: 1.36–7.87, p = 0.008) for scores of −1 to 0 (n = 303) and 12.12 (95% CI: 4.19–35.07, p < 0.001) for scores of 1 to 2 (n = 35) relative to a score of −2 (n = 103). The GRS based on the four SNPs could help identify at-risk individuals and enable implementation of preventive measures for vertebral fracture. Keywords: Genetic risk score, Osteoporosis, Single-nucleotide polymorphism, Vertebral fracture